Privia Health Group, Inc. provided revenue guidance for the fiscal year 2022. GAAP revenue to be $1,225 million to $1,300 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.16 USD | -1.89% | -1.21% | -25.49% |
30/05 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
20/05 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.49% | 208.69Cr | |
+24.64% | 8.82TCr | |
-21.80% | 7.65TCr | |
+1.76% | 2.7TCr | |
+7.94% | 1.86TCr | |
-13.78% | 1.67TCr | |
+3.20% | 1.58TCr | |
+77.35% | 1.34TCr | |
+76.83% | 1.32TCr | |
+23.04% | 1.27TCr |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group, Inc. Provides Revenue Guidance for the Fiscal Year 2022